Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial (Q28550715)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial	scientific article

Statements

scholarly article

0 references

Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial (English)

0 references

infectious disease

0 references

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

object named as

Loa loa

1 reference

based on heuristic

inferred from title

Patrick Nguipdop-Djomo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Annette C. Kuesel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

object named as

Joseph Kamgno

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Raceline Gounoue

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mathurin Téjiokem

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

0 references

publication date

March 2016

0 references

PLoS Neglected Tropical Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

e0004492

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

copyright license

Creative Commons Attribution 4.0 International

11 March 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

19 March 2017

A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

19 March 2017

Five cases of encephalitis during treatment of loiasis with diethylcarbamazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

19 March 2017

Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

The Wolbachia endosymbiont as an anti-filarial nematode target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

The biochemical basis of anthelmintic action and resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Albendazole: a review of anthelmintic efficacy and safety in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Loasis as a possible trigger of African endomyocardial fibrosis: a case report from Nigeria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

29 September 2017

Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Modes of action of anthelmintic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Ascending paralysis associated with diethylcarbamazine treatment of M. loa loa infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

3 June 2018

Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Ivermectin-based control of onchocerciasis in northern Cameroon: individual factors influencing participation in community treatment.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Dose dependent pharmacokinetics of albendazole in human.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Time dependent pharmacokinetics of albendazole in human

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

COMPARISON OF FLUBENDAZOLE AND DIETHYLCARBAMAZINE IN TREATMENT OF ONCHOCERCIASIS

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004492

21 January 2018

Human loiasis in a Cameroonian village: A double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788450

27 November 2018

Albendazole, a broad-spectrum anthelmintic, in the treatment of intestinal nematode and cestode infection: a multicenter study in 480 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loiasis--a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albendazole in human loiasis: results of a double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0004492

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967331%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28550715&oldid=1853304796"